XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED)
$ in Thousands
 9 Months Ended
Mar. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
Jun. 30, 2023
USD ($)
OPERATING ACTIVITIES      
Net income $ 75,585 $ 75,407  
Adjustments to reconcile to cash from operations:      
Depreciation 93,279 91,056  
Amortization 8,142 8,674  
Stock-based compensation expense 18,329 20,651  
Restructuring and other charges, net (Note 6) 7,535 10,585  
Insurance Recoveries (7,500) 0  
Other Noncash Income (Expense) 817 13,511  
Deferred income taxes (1,917) (7,661)  
Changes in certain assets and liabilities:      
Accounts receivable 10,516 3,875  
Inventories (41,269) 7,044  
Accounts payable and accrued liabilities (14,140) (26,014)  
Accrued income taxes (11,668) (17,459)  
Accrued pension and postretirement benefits (5,023) (8,529)  
Other (2,956) (7,680)  
Net cash flow provided by (used in) operating activities 129,730 163,460  
INVESTING ACTIVITIES      
Purchases of property, plant and equipment (67,506) (84,240)  
Disposals of property, plant and equipment 460 5,270  
Payments to Acquire Businesses, Net of Cash Acquired 0 4,010  
Proceeds from Insurance Settlement, Investing Activities 7,193 0  
Other (202) (3,131)  
Net cash flow used in investing activities (60,055) (86,111)  
FINANCING ACTIVITIES      
Net increase in notes payable 944 4,132  
Net increase in revolving and other lines of credit 10,200 7,500  
Purchase of capital stock (55,081) (43,786)  
The effect of employee benefit and stock plans and dividend reinvestment (6,570) (7,949)  
Cash dividends paid to Shareholders (46,604) (47,697)  
Other (915) (859)  
Net cash flow (used in) provided by financing activities (98,026) (88,659)  
Effect of exchange rate changes on cash and cash equivalents (2,153) (2,592)  
Net decrease in cash and cash equivalents (30,504) (13,902)  
Cash and cash equivalents, end of period $ 97,467 $ 92,119 $ 106,021